SAPHNELO conc perf 300 mg/2ml flac
7680685120014
CH-68512
L04AG11
07.15.0.
Reimbursement limitations:
SAPHNELO
La prescription initiale est réservée aux spécialistes en immunologie clinique ou en rhumatologie.
Après la …
1 / 3
google
Details
- Product number
- 6851201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- anifrolumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, lysini hydrochloridum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Saphnelo 300 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 990.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68512
- Drug name
- Saphnelo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG11
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 31/08/2022
- Authorization expiration date
- 30/08/2027
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SAPHNELO conc perf 300 mg/2ml flac
- Description (DE)
- SAPHNELO Inf Konz 300 mg/2ml Durchstf
- Market launch
- 31/08/2022
- Narcotic (BTM)
- No